US Broker Ratings

Avantor, Inc. (AVTR) Stock Analysis: Exploring a 20.63% Potential Upside Amidst Challenging Metrics

Avantor, Inc. (NYSE: AVTR), a prominent player in the Healthcare sector, specifically within the Medical Instruments & Supplies industry, finds itself at a critical juncture. With a market capitalization of..

The Ensign Group, Inc. (ENSG) Stock Analysis: A Healthcare Player with Robust Revenue Growth and Potential Upside

The Ensign Group, Inc. (NASDAQ: ENSG) stands out as a significant player in the healthcare sector, specifically within the medical care facilities industry. With a market capitalization of $12.24 billion,..

Quest Diagnostics (DGX) Stock Analysis: Strong Revenue Growth and a Promising 7.39% Potential Upside

Quest Diagnostics Incorporated (NYSE: DGX) stands as a formidable player in the healthcare sector, specifically within the diagnostics and research industry. With a market capitalization of $22.52 billion, Quest Diagnostics..

BioMarin Pharmaceutical Inc. (BMRN) Stock Analysis: A 38.69% Potential Upside in the Biotech Sector

BioMarin Pharmaceutical Inc. (NASDAQ: BMRN), a leading biotechnology firm headquartered in San Rafael, California, is making significant strides in the healthcare sector by pioneering therapies for rare and life-threatening diseases...

Boston Scientific Corporation (BSX) Stock Analysis: Evaluating a 40% Potential Upside with Strong Buy Ratings

Boston Scientific Corporation (NYSE: BSX), a titan in the medical device industry, presents an enticing opportunity for investors with a robust market capitalization of $110.6 billion. As a leader in..

Teva Pharmaceutical Industries (TEVA) Stock Analysis: Navigating an 11.18% Potential Upside

Teva Pharmaceutical Industries (NYSE: TEVA), a stalwart in the healthcare sector, is garnering significant investor attention. With a market capitalization of $39.85 billion, Teva is a key player in the..

Becton, Dickinson and Company (BDX) Stock Analysis: Assessing Growth Potential with a 5.39% Upside

Becton, Dickinson and Company (NYSE: BDX), a stalwart in the healthcare sector, continues to capture investor attention with its robust market presence and diverse product offerings in the medical instruments..

HealthEquity, Inc. (HQY) Investor Outlook: Exploring a Potential 46% Upside with Strong Buy Ratings

HealthEquity, Inc. (NASDAQ: HQY), a leader in technology-enabled health savings solutions, is drawing significant investor interest thanks to its robust growth potential and compelling valuation metrics. With an average analyst..

ResMed Inc. (RMD) Stock Analysis: A Healthcare Leader with 14.8% Potential Upside

ResMed Inc. (NYSE: RMD) is a prominent player in the healthcare sector, specializing in medical instruments and supplies. With a market capitalization of $37.82 billion, ResMed is a formidable force..

Novo Nordisk A/S (NVO) Stock Analysis: A 13.84% Upside Potential Amid Healthcare Sector Challenges

Novo Nordisk A/S (NYSE: NVO), a heavyweight in the healthcare sector with a market cap of $210.86 billion, has long been a key player in the pharmaceutical industry. Specializing in..

West Pharmaceutical Services, Inc. (WST) Stock Analysis: Unveiling a 32% Potential Upside

West Pharmaceutical Services, Inc. (NYSE: WST) is a key player in the healthcare sector, specifically within the medical instruments and supplies industry. With its headquarters in Exton, Pennsylvania, the company..

Summit Therapeutics Inc. (SMMT) Stock Analysis: Unpacking a 103.76% Potential Upside in the Biotech Space

Summit Therapeutics Inc. (NASDAQ: SMMT) is an intriguing player in the healthcare sector, specifically within the biotechnology industry. Headquartered in Miami, Florida, and boasting a market capitalization of $11.87 billion,..

Doximity, Inc. (DOCS) Stock Analysis: Exploring a 56% Potential Upside in the Health Information Sector

Doximity, Inc. (DOCS), a prominent player in the healthcare technology sector, offers a compelling investment proposition with a potential upside of 56.37% based on its average target price. Operating as..

Intuitive Surgical, Inc. (ISRG) Stock Analysis: Exploring a 21% Potential Upside

Intuitive Surgical, Inc. (ISRG), a titan within the healthcare sector, continues to capture investor interest with its cutting-edge medical instruments and robust market presence. With a substantial market cap of..

Genmab A/S (GMAB) Stock Analysis: A Biotech Powerhouse with 29.55% Potential Upside

For investors with an eye on the healthcare sector, Genmab A/S (NASDAQ: GMAB) presents a compelling opportunity within the biotechnology industry. Headquartered in Copenhagen, Denmark, Genmab has established itself as..

Medtronic plc (MDT) Stock Analysis: Exploring a 15.39% Upside Potential in the Healthcare Sector

Medtronic plc (MDT), a behemoth in the healthcare sector with a market capitalization of $124.23 billion, stands as a pivotal player in the medical devices industry. Headquartered in Galway, Ireland,..

Smith & Nephew SNATS, Inc. (SNN) Stock Analysis: Exploring Growth Potential in the Medical Devices Sector

Smith & Nephew SNATS, Inc. (NYSE: SNN), a major player in the global medical devices market, is drawing attention from investors with its promising growth prospects and stable financial performance...

Dr. Reddy’s Laboratories Ltd (RDY) Stock Analysis: Navigating a -0.37% Potential Downside Amidst Global Expansion

Dr. Reddy’s Laboratories Ltd (NYSE: RDY), a prominent player in the healthcare sector, operates as a leading pharmaceutical company with a robust presence in North America, Europe, India, and beyond...

ICON plc (ICLR) Stock Analysis: Exploring the 58% Potential Upside in the Healthcare Sector

ICON plc (NASDAQ: ICLR), a prominent player in the healthcare sector, stands as a beacon of interest for investors looking to capitalize on the healthcare industry’s dynamic landscape. With a..

Regeneron Pharmaceuticals (REGN) Stock Analysis: Navigating Growth with a Promising 11.58% Upside

Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) stands as a prominent player in the biotechnology sector, consistently pioneering advancements in healthcare through the discovery and commercialization of innovative medicines. As of its..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds